Ledger.Open graph →
SEC Form D · Amendment · filed August 24, 2022

Nocion Therapeutics, Inc

Offering
$17.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Michael P. Higgins · WALTHAM, MADirectorRichard Batycky · WALTHAM, MAExec · DirectorJames M. Ellis · WALTHAM, MAExecJessica M. Alston · WALTHAM, MADirectorMeredith M. Fisher · WALTHAM, MADirectorMichael M. Lipp · WALTHAM, MAExecChristopher M. Silber · WALTHAM, MAExecBridget M. Cole · WALTHAM, MAExecJulie P. Grant · WALTHAM, MADirectorConor Quinn · Malibu, CAExecDavid Fisher · WEST HOLLYWOOD, CADirectorTheo Osborne · WEST HOLLYWOOD, CADirectorDaniel M. Plourde · Rye, NYDirectorStuart Hall · Malibu, CAExecBrian Prokop · McAllen, TXExec · DirectorFeisal Somji · McAllen, TXExecDavid W. Korstad · Miami, FLDirectorRaul Ramirez · McAllen, TXExecJonathan P. Garen · WALTHAM, MAExecBrandon Black · Richmond, VADirectorLisa Fischer · Richmond, VADirectorStephen Remondi · Boston, MADirectorEthan Vallarino · Newmarket, NHExecAnton M. Simunovic · Manchester, NHExecLauren M. Kolodny · Manchester, NHExecDavid M. Lang · Manchester, NHExec · DirectorRyan J. Gofus · Hoboken, NJExecDaniel B. Scandian · Grand Cayman, Cayman IslandsDirectorJonathan P. Garen · WALTHAM, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗